Tianda Pharmaceuticals Ltd. (HK:0455) has released an update.
Tianda Pharmaceuticals Ltd. has announced unanimous approval for all proposed resolutions at their Annual General Meeting on June 7, 2024, including the adoption of audited financial statements, declaration of dividends, re-election of board members, and the re-appointment of Ernst & Young as auditors. Shareholders showed overwhelming support, with 100% of votes in favor of the actions, which also included mandates related to share repurchases and issuance.
For further insights into HK:0455 stock, check out TipRanks’ Stock Analysis page.